Edwin Rock, M.D.

Edwin Rock, M.D.

-Chief Medical Officer and Senior Vice PresidentatCrescent Biopharma· In the 2023 proxy

Pay in FY2023Crescent Biopharma stock -22.1% the same year

Edwin Rock, M.D. was paid $1.2M in FY2023 (Dec). Crescent Biopharma stock fell 22.1% that year.

Pay$100 in the stock at the end of FY22 → $78
Pay is from the Summary Compensation Table of each Crescent Biopharma proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Crescent BiopharmaPublic company · 3 yr
    • -Chief Medical Officer and Senior Vice President2023 – Present · 3 yrStock in role -94%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?